Researchers from the U-M Rogel Cancer Center are interested in a new form of pancreatic cancer treatment that disrupts cell “crosstalk” and resulting tumor growth. A new study discusses recent findings on mitochondrial metabolism, a key driver of pancreatic cancer. The authors discuss their research and the potential for new treatments.
